Skip to main content
Top
Published in: Molecular Cancer 1/2010

Open Access 01-12-2010 | Research

Nuclear export regulation of COP1 by 14-3-3σ in response to DNA damage

Authors: Chun-Hui Su, Ruiying Zhao, Guermarie Velazquez-Torres, Jian Chen, Christopher Gully, Sai-Ching J Yeung, Mong-Hong Lee

Published in: Molecular Cancer | Issue 1/2010

Login to get access

Abstract

Mammalian constitutive photomorphogenic 1 (COP1) is a p53 E3 ubiquitin ligase involved in regulating p53 protein level. In plants, the dynamic cytoplasm/nucleus distribution of COP1 is important for its function in terms of catalyzing the degradation of target proteins. In mammalian cells, the biological consequence of cytoplasmic distribution of COP1 is not well characterized. Here, we show that DNA damage leads to the redistribution of COP1 to the cytoplasm and that 14-3-3σ, a p53 target gene product, controls COP1 subcellular localization. Investigation of the underlying mechanism suggests that COP1 S387 phosphorylation is required for COP1 to bind 14-3-3σ. Significantly, upon DNA damage, 14-3-3σ binds to phosphorylated COP1 at S387, resulting in COP1's accumulation in the cytoplasm. Cytoplasmic COP1 localization leads to its enhanced ubiquitination. We also show that N-terminal 14-3-3σ interacts with COP1 and promotes COP1 nuclear export through its NES sequence. Further, we show that COP1 is important in causing p53 nuclear exclusion. Finally, we demonstrate that 14-3-3σ targets COP1 for nuclear export, thereby preventing COP1-mediated p53 nuclear export. Together, these results define a novel, detailed mechanism for the subcellular localization and regulation of COP1 after DNA damage and provide a mechanistic explanation for the notion that 14-3-3σ's impact on the inhibition of p53 E3 ligases is an important step for p53 stabilization after DNA damage.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hardtke CS, Gohda K, Osterlund MT, Oyama T, Okada K, Deng XW: HY5 stability and activity in arabidopsis is regulated by phosphorylation in its COP1 binding domain. Embo J. 2000, 19: 4997-5006. 10.1093/emboj/19.18.4997PubMedCentralCrossRefPubMed Hardtke CS, Gohda K, Osterlund MT, Oyama T, Okada K, Deng XW: HY5 stability and activity in arabidopsis is regulated by phosphorylation in its COP1 binding domain. Embo J. 2000, 19: 4997-5006. 10.1093/emboj/19.18.4997PubMedCentralCrossRefPubMed
2.
go back to reference Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM: The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature. 2004, 429: 86-92. 10.1038/nature02514CrossRefPubMed Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM: The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature. 2004, 429: 86-92. 10.1038/nature02514CrossRefPubMed
3.
go back to reference Bianchi E, Denti S, Catena R, Rossetti G, Polo S, Gasparian S, Putignano S, Rogge L, Pardi R: Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity. J Biol Chem. 2003, 278: 19682-19690. 10.1074/jbc.M212681200CrossRefPubMed Bianchi E, Denti S, Catena R, Rossetti G, Polo S, Gasparian S, Putignano S, Rogge L, Pardi R: Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity. J Biol Chem. 2003, 278: 19682-19690. 10.1074/jbc.M212681200CrossRefPubMed
4.
go back to reference Wertz IE, O'Rourke KM, Zhang Z, Dornan D, Arnott D, Deshaies RJ, Dixit VM: Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science. 2004, 303: 1371-1374. 10.1126/science.1093549CrossRefPubMed Wertz IE, O'Rourke KM, Zhang Z, Dornan D, Arnott D, Deshaies RJ, Dixit VM: Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science. 2004, 303: 1371-1374. 10.1126/science.1093549CrossRefPubMed
5.
go back to reference Savio MG, Rotondo G, Maglie S, Rossetti G, Bender JR, Pardi R: COP1 D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1. Oncogene. 2008, 27: 2401-2411. 10.1038/sj.onc.1210892CrossRefPubMed Savio MG, Rotondo G, Maglie S, Rossetti G, Bender JR, Pardi R: COP1 D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1. Oncogene. 2008, 27: 2401-2411. 10.1038/sj.onc.1210892CrossRefPubMed
6.
go back to reference Dentin R, Liu Y, Koo SH, Hedrick S, Vargas T, Heredia J, Yates J, Montminy M: Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature. 2007, 449: 366-369. 10.1038/nature06128CrossRefPubMed Dentin R, Liu Y, Koo SH, Hedrick S, Vargas T, Heredia J, Yates J, Montminy M: Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature. 2007, 449: 366-369. 10.1038/nature06128CrossRefPubMed
7.
go back to reference Kato S, Ding J, Pisck E, Jhala US, Du K: COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. J Biol Chem. 2008, 283: 35464-35473. 10.1074/jbc.M801011200PubMedCentralCrossRefPubMed Kato S, Ding J, Pisck E, Jhala US, Du K: COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. J Biol Chem. 2008, 283: 35464-35473. 10.1074/jbc.M801011200PubMedCentralCrossRefPubMed
8.
go back to reference Li DQ, Ohshiro K, Reddy SD, Pakala SB, Lee MH, Zhang Y, Rayala SK, Kumar R: E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proc Natl Acad Sci USA. 2009, 106: 17493-17498. 10.1073/pnas.0908027106PubMedCentralCrossRefPubMed Li DQ, Ohshiro K, Reddy SD, Pakala SB, Lee MH, Zhang Y, Rayala SK, Kumar R: E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proc Natl Acad Sci USA. 2009, 106: 17493-17498. 10.1073/pnas.0908027106PubMedCentralCrossRefPubMed
9.
go back to reference Dornan D, Shimizu H, Mah A, Dudhela T, Eby M, O'Rourke K, Seshagiri S, Dixit VM: ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science. 2006, 313: 1122-1126. 10.1126/science.1127335CrossRefPubMed Dornan D, Shimizu H, Mah A, Dudhela T, Eby M, O'Rourke K, Seshagiri S, Dixit VM: ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science. 2006, 313: 1122-1126. 10.1126/science.1127335CrossRefPubMed
10.
go back to reference Lee MH, Lozano G: Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins. Semin Cancer Biol. 2006, 16: 225-234. 10.1016/j.semcancer.2006.03.009CrossRefPubMed Lee MH, Lozano G: Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins. Semin Cancer Biol. 2006, 16: 225-234. 10.1016/j.semcancer.2006.03.009CrossRefPubMed
11.
go back to reference Fu H, Subramanian RR, Masters SC: 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol. 2000, 40: 617-647. 10.1146/annurev.pharmtox.40.1.617CrossRefPubMed Fu H, Subramanian RR, Masters SC: 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol. 2000, 40: 617-647. 10.1146/annurev.pharmtox.40.1.617CrossRefPubMed
12.
go back to reference Michaud NR, Fabian JR, Mathes KD, Morrison DK: 14-3-3 is not essential for Raf-1 function: identification of Raf-1 proteins that are biologically activated in a 14-3-3-and Ras-independent manner. Mol Cell Biol. 1995, 15: 3390-3397.PubMedCentralCrossRefPubMed Michaud NR, Fabian JR, Mathes KD, Morrison DK: 14-3-3 is not essential for Raf-1 function: identification of Raf-1 proteins that are biologically activated in a 14-3-3-and Ras-independent manner. Mol Cell Biol. 1995, 15: 3390-3397.PubMedCentralCrossRefPubMed
13.
go back to reference Prasad GL, Valverius EM, McDuffie E, Cooper HL: Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be downregulated in neoplastic mammary cells. Cell Growth Differ. 1992, 3: 507-513.PubMed Prasad GL, Valverius EM, McDuffie E, Cooper HL: Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be downregulated in neoplastic mammary cells. Cell Growth Differ. 1992, 3: 507-513.PubMed
14.
go back to reference Verdoodt B, Benzinger A, Popowicz GM, Holak TA, Hermeking H: Characterization of 14-3-3sigma dimerization determinants: requirement of homodimerization for inhibition of cell proliferation. Cell Cycle. 2006, 5: 2920-2926. 10.4161/cc.5.24.3571CrossRefPubMed Verdoodt B, Benzinger A, Popowicz GM, Holak TA, Hermeking H: Characterization of 14-3-3sigma dimerization determinants: requirement of homodimerization for inhibition of cell proliferation. Cell Cycle. 2006, 5: 2920-2926. 10.4161/cc.5.24.3571CrossRefPubMed
15.
16.
go back to reference Yang HY, Wen YY, Chen CH, Lozano G, Lee MH: 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol Cell Biol. 2003, 23: 7096-7107. 10.1128/MCB.23.20.7096-7107.2003PubMedCentralCrossRefPubMed Yang HY, Wen YY, Chen CH, Lozano G, Lee MH: 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol Cell Biol. 2003, 23: 7096-7107. 10.1128/MCB.23.20.7096-7107.2003PubMedCentralCrossRefPubMed
17.
go back to reference Yang HY, Wen YY, Lin YI, Pham L, Su CH, Yang H, Chen J, Lee MH: Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities. Oncogene. 2007, 26: 7355-7362. 10.1038/sj.onc.1210540CrossRefPubMed Yang HY, Wen YY, Lin YI, Pham L, Su CH, Yang H, Chen J, Lee MH: Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities. Oncogene. 2007, 26: 7355-7362. 10.1038/sj.onc.1210540CrossRefPubMed
18.
go back to reference Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY, Qiu Y, Diaz J, Laronga C, Lee MH: DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res. 2006, 66: 3096-3105. 10.1158/0008-5472.CAN-05-3620CrossRefPubMed Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY, Qiu Y, Diaz J, Laronga C, Lee MH: DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res. 2006, 66: 3096-3105. 10.1158/0008-5472.CAN-05-3620CrossRefPubMed
19.
go back to reference Laronga C, Yang HY, Neal C, Lee MH: Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem. 2000, 275: 23106-23112. 10.1074/jbc.M905616199CrossRefPubMed Laronga C, Yang HY, Neal C, Lee MH: Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem. 2000, 275: 23106-23112. 10.1074/jbc.M905616199CrossRefPubMed
20.
go back to reference Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B: 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell. 1997, 1: 3-11. 10.1016/S1097-2765(00)80002-7CrossRefPubMed Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B: 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell. 1997, 1: 3-11. 10.1016/S1097-2765(00)80002-7CrossRefPubMed
21.
go back to reference Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B: 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature. 1999, 401: 616-620. 10.1038/44188CrossRefPubMed Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B: 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature. 1999, 401: 616-620. 10.1038/44188CrossRefPubMed
22.
go back to reference Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, Gamblin SJ, Smerdon SJ, Cantley LC: The structural basis for 14-3-3:phosphopeptide binding specificity. Cell. 1997, 91: 961-971. 10.1016/S0092-8674(00)80487-0CrossRefPubMed Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, Gamblin SJ, Smerdon SJ, Cantley LC: The structural basis for 14-3-3:phosphopeptide binding specificity. Cell. 1997, 91: 961-971. 10.1016/S0092-8674(00)80487-0CrossRefPubMed
23.
go back to reference Ziv Y, Bar-Shira A, Pecker I, Russell P, Jorgensen TJ, Tsarfati I, Shiloh Y: Recombinant ATM protein complements the cellular A-T phenotype. Oncogene. 1997, 15: 159-167. 10.1038/sj.onc.1201319CrossRefPubMed Ziv Y, Bar-Shira A, Pecker I, Russell P, Jorgensen TJ, Tsarfati I, Shiloh Y: Recombinant ATM protein complements the cellular A-T phenotype. Oncogene. 1997, 15: 159-167. 10.1038/sj.onc.1201319CrossRefPubMed
24.
go back to reference Osterlund MT, Wei N, Deng XW: The roles of photoreceptor systems and the COP1-targeted destabilization of HY5 in light control of Arabidopsis seedling development. Plant Physiol. 2000, 124: 1520-1524. 10.1104/pp.124.4.1520PubMedCentralCrossRefPubMed Osterlund MT, Wei N, Deng XW: The roles of photoreceptor systems and the COP1-targeted destabilization of HY5 in light control of Arabidopsis seedling development. Plant Physiol. 2000, 124: 1520-1524. 10.1104/pp.124.4.1520PubMedCentralCrossRefPubMed
25.
go back to reference Osterlund MT, Hardtke CS, Wei N, Deng XW: Targeted destabilization of HY5 during light-regulated development of Arabidopsis. Nature. 2000, 405: 462-466. 10.1038/35013076CrossRefPubMed Osterlund MT, Hardtke CS, Wei N, Deng XW: Targeted destabilization of HY5 during light-regulated development of Arabidopsis. Nature. 2000, 405: 462-466. 10.1038/35013076CrossRefPubMed
26.
go back to reference Stommel JM, Wahl GM: Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. Embo J. 2004, 23: 1547-1556. 10.1038/sj.emboj.7600145PubMedCentralCrossRefPubMed Stommel JM, Wahl GM: Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. Embo J. 2004, 23: 1547-1556. 10.1038/sj.emboj.7600145PubMedCentralCrossRefPubMed
Metadata
Title
Nuclear export regulation of COP1 by 14-3-3σ in response to DNA damage
Authors
Chun-Hui Su
Ruiying Zhao
Guermarie Velazquez-Torres
Jian Chen
Christopher Gully
Sai-Ching J Yeung
Mong-Hong Lee
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2010
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-9-243

Other articles of this Issue 1/2010

Molecular Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine